-
Anti-inflammatory/Antioxidant/Antibacterial Agent
Eukovoside is a cinnamic acid derivative that primarily exerts anti-inflammatory, antioxidant, and antibacterial effects. This compound shows potential in the study of hyperglycemic diseases and is useful for investigating various inflammatory conditions, including eye inflammation and respiratory tract disorders. Additionally, Eukovoside may contribute to research focused on allergic responses such as hay fever and conjunctivitis, as well as infections like colds, influenza, and sinusitis. -
Antibacterial Agent
Ostruthin is a natural coumarin compound that exerts antibacterial and antimycobacterial activities. It effectively inhibits the growth of mycobacteria and Staphylococcus aureus, making it valuable in studies of bacterial pathogenesis. Additionally, ostruthin suppresses vascular smooth muscle cell proliferation and de novo DNA synthesis, positioning it as a pertinent tool for research related to mycobacterial infections and cardiovascular as well as cerebrovascular diseases. -
Bacterial Inhibitor
Mequindox is an antimicrobial agent that functions as a bacterial inhibitor by selectively targeting and inhibiting DNA synthesis. This compound demonstrates significant genotoxic and carcinogenic effects in murine models, making it a valuable tool for studying bacterial resistance mechanisms and the potential impacts of antimicrobial agents on genetic material. Its applications extend to research on the safety and efficacy of antimicrobial treatments in various biological systems. -
Bacterial Inhibitor
Silver sulfadiazine is a sulfonamide antibiotic that functions as a bacterial inhibitor through dual mechanisms. The sulfa moiety inhibits bacterial folate absorption, thereby disrupting essential DNA synthesis. Additionally, silver ions released from silver sulfadiazine bind to and disrupt DNA structures, preventing bacterial DNA replication. This compound is widely used in research applications focusing on bacterial growth inhibition and antimicrobial studies. -
Antibacterial Agent
Amicoumacin B is an antibacterial agent produced by the actinomycete strain 04-5195T, primarily targeting bacterial quorum sensing mechanisms. It demonstrates significant inhibitory activity against Chromobacterium violaceum, with a minimum inhibitory concentration (MIC) of 250 µg/mL. Additionally, Amicoumacin B upregulates the expression of bone morphogenetic protein 2 (BMP-2) while simultaneously inhibiting the expression of essential quorum sensing operons vioA, vioB, vioD, and vioE, and enhancing vioC expression. These properties make Amicoumacin B a valuable tool in microbiological research and the study of bacterial communication. -
Bacterial Inhibitor
Fenvalerate is a highly effective bacterial inhibitor, primarily functioning as a protein phosphatase 2B (calcineurin) inhibitor, with an IC50 of 2-4 nM for PP2B-Aα. As a pyrethroid ester, it exhibits significant insecticidal and acaricidal properties. This compound is utilized in various research applications to study protein phosphatase signaling pathways and to explore potential therapeutic targets in bacterial infections. -
Antibacterial Peptide
Golotimod hydrochloride is an immunomodulating peptide that targets antibacterial pathways. This compound enhances the efficacy of antituberculosis therapy by promoting thymic and splenic cell proliferation and improving macrophage functionality. Additionally, Golotimod hydrochloride inhibits STAT3 signaling, thereby modulating the severity and duration of oral mucositis in animal models subjected to radiation or combined treatments. Furthermore, it shows promise as a therapeutic agent for recurrent genital herpes simplex virus type 2 (HSV-2). -
Antibacterial Peptide
Golotimod TFA is an immunomodulating peptide primarily known for its antibacterial properties. This compound enhances the efficacy of antituberculosis therapy and promotes thymic and splenic cell proliferation while improving macrophage function. It inhibits STAT3 signaling, demonstrating potential in mitigating the duration and severity of oral mucositis in irradiated animal models. Additionally, Golotimod TFA shows promise as a therapeutic agent for recurrent genital herpes simplex virus type 2 (HSV-2). -
Anti-inflammatory/antibacterial Agent
Plumericin is an anti-inflammatory and antibacterial agent that primarily targets key signaling pathways involved in inflammation and cellular stress response. It has been shown to reduce apoptosis, activate Nrf-2, and inhibit both NF-κB and AhR activation, while also blocking STAT3 signaling. Plumericin exhibits inhibitory effects on Mycobacterium tuberculosis growth, making it a valuable compound for studying chronic kidney disease, vascular diseases, inflammatory bowel diseases, peritonitis, and tuberculosis. -
Antibacterial Agent/Growth-promoting Agent
Quindoxin is an antibacterial agent that acts by disrupting bacterial cell function. It demonstrates significant growth-promoting activity, particularly in livestock, and has been shown to exhibit dose-dependent mutagenicity against Salmonella typhimurium strains TA98 and TA100. Additionally, Quindoxin is associated with potential DNA damage, highlighting its relevance in studies related to genotoxicity and carcinogenicity. -
Bacterial Transcription Inhibitor
GKL003 is a bacterial transcription inhibitor that targets the interaction interface of RNA polymerase (RNAP) and the sigma factor, with a Ki value of 5.79 nM. By specifically binding to the RNAP β' clamp helix region at the σA factor binding site, GKL003 disrupts the formation of the RNAP holoenzyme and inhibits bacterial transcription initiation complexes. This compound effectively inhibits the growth of both Gram-positive and Gram-negative bacterial strains, including those that are drug-resistant, making it a valuable tool for research applications in microbiology and antibiotic resistance studies. -
Antitumor/ Antibacterial Agent
Epanorin is a secondary metabolite derived from the Acarospora lichenic species, primarily targeting tumor cells and bacterial pathogens. It exhibits potent antitumor activity by inhibiting cancer cell proliferation, reducing reactive oxygen species (ROS) production, and inducing cell cycle arrest in the G0/G1 phase. Additionally, Epanorin demonstrates antibacterial properties, making it valuable for research applications focused on cancer treatment and bacterial infections, including studies on breast cancer and Streptococcus pneumoniae infections. -
Antibacterial Agent
Deoxymikanolide is an orally active antibacterial agent that primarily targets catalase (CAT), peroxidase (POD), and superoxide dismutase (SOD) activities. It enhances glycan and phosphorus metabolism, increases electrical conductivity, and elevates levels of intrabacterial reactive oxygen species (ROS) and malondialdehyde (MDA). These actions result in cell shrinkage, cytoplasmic damage, and disruption in Ralstonia solanacearum. Additionally, Deoxymikanolide demonstrates efficacy in inhibiting acetic acid-induced writhing in mice, making it a valuable tool for research on bacterial wilt. -
Antibacterial Peptide
KSL-W is a multifunctional antibacterial peptide primarily targeting immune regulation. It exhibits significant chemotactic effects on neutrophils and promotes F-actin polymerization through the Gαi protein signaling pathway. Additionally, KSL-W effectively inhibits the production of reactive oxygen species (ROS) in neutrophils. This peptide is valuable for research focused on infection control and the regulation of inflammatory processes. -
Antibacterial Agent
Aloe vera, a natural herbal extract, exhibits significant antibacterial activity. It is recognized for its anti-inflammatory and antioxidant properties, making it a valuable candidate for research applications in areas such as tumor biology, diabetes, bone disorders, and cardiovascular health. Its diverse biological effects support its potential use as a therapeutic agent in various biomedical studies. -
Antibacterial Agent
ROS inducer 9 is an antibacterial agent that functions by inhibiting glutathione (GSH) activity and elevating reactive oxygen species (ROS) levels. With a minimum inhibitory concentration (MIC) of 0.25 μg/mL against E. coli, it demonstrates potent antibacterial properties. Additionally, ROS inducer 9 exhibits low toxicity to erythrocytes and RAW 264.7 cells, making it suitable for various biological research applications in exploring oxidative stress responses in bacterial infections. -
Anti-bacterial Agent
Anti-MRSA agent 36 is an antibacterial compound that exhibits potent activity against methicillin-resistant Staphylococcus aureus (MRSA), with a minimum inhibitory concentration (MIC) of 1 μg/mL. This agent specifically targets phosphatidylglycerol (PG) in bacterial membranes, leading to compromised membrane integrity, DNA leakage, and increased reactive oxygen species (ROS) production. Characterized by low cytotoxicity and minimal hemolytic effect, Anti-MRSA agent 36 also demonstrates a reduced propensity for inducing drug resistance and good plasma stability, making it suitable for research involving skin abscess and systemic infection models. -
Antibacterial Agent
Antibacterial Agent 308 is an antibacterial compound that selectively targets bacterial membranes by binding to phosphatidylethanolamine, leading to membrane polarization disruption and increased intracellular reactive oxygen species (ROS) levels. This agent exhibits significant anti-biofilm activity against Staphylococcus aureus and demonstrates potent anti-methicillin-resistant Staphylococcus aureus (MRSA) efficacy. Its unique mechanism makes it a valuable tool for research focused on combating bacterial infections and biofilm-related challenges. -
Antibacterial Agent
3,4-Dimethoxychalcone acts as an antibacterial agent by inducing deacetylation of cytoplasmic proteins, thereby promoting autophagy flux. This compound is relevant for research applications focused on disease mechanisms related to cardiac and cancer biology, offering potential pathways for therapeutic intervention. Researchers may explore its effects on cellular processes and its role as a caloric restriction mimetic in various experimental models. -
Antibacterial Agent
BWC0977 is an antibacterial agent that primarily targets bacterial DNA replication by inhibiting DNA gyrase and topoisomerase IV. This compound demonstrates potent activity with a minimum inhibitory concentration (MIC90) ranging from 0.03 to 2 µg/mL against multi-drug resistant Gram-negative bacteria. BWC0977 is suitable for research applications involving the study of bacterial resistance mechanisms and the development of new antimicrobial strategies. -
Antibacterial Agent
BWC0977 formic is an antibacterial agent that targets bacterial DNA replication by inhibiting DNA gyrase and topoisomerase IV. It demonstrates significant antibacterial activity, with a minimum inhibitory concentration (MIC90) ranging from 0.03 to 2 µg/mL against multi-drug resistant Gram-negative bacteria. This compound is valuable for research applications focused on combating antibiotic resistance and exploring therapeutic strategies for resistant infections. -
Antibacterial Agent
Antibacterial Agent 89 is a potent antibacterial compound that targets bacterial transcription processes. It exhibits significant anti-clostridial activity by inhibiting the release of cytotoxins and disrupting the β’CH-σ interaction. This compound is useful for research applications focused on bacterial pathogenesis and the development of novel antibacterial strategies. -
Bacterial DNA Gyrase/Topo IV Inhibitor
GC-072 is a selective inhibitor of bacterial DNA gyrase and Topoisomerase IV, demonstrating potent antibacterial activity. This 4-oxoquinolizine antibiotic exhibits efficacy against a wide range of bacterial strains, including Gram-positive, Gram-negative, and multidrug-resistant organisms. Importantly, GC-072 does not interfere with human topoisomerases I and II, making it a suitable candidate for studying bacterial infections. Its bactericidal action against Burkholderia pseudomallei is significant, as it supports dose-dependent survival rates in mice during lethal inhalational models, highlighting its potential in melioidosis research. -
Bacterial DNA Gyrase B Inhibitor
DNA Gyrase-IN-3 is a specific inhibitor of bacterial DNA gyrase B, exhibiting IC50 values ranging from 5.41 to 15.64 µM against E. coli DNA gyrase. This compound demonstrates significant anti-tubercular and antibacterial activity, making it a valuable tool for microbial research. Its mechanism of action is relevant in studies aimed at developing new antibacterial agents targeting bacterial DNA replication and transcription processes. -
Bacterial Inhibitor
CI-990 (PD-131112) is a selective inhibitor of bacterial DNA gyrase, targeting key enzymes involved in DNA replication and repair. It exhibits potent antibacterial activity and is especially relevant for studying Enterococcal infections, including endocarditis and sepsis. This compound can serve as a valuable tool in microbiological research to understand bacterial resistance mechanisms and develop therapeutic strategies. -
Bacterial Transcription Inhibitor
CUHK242 is a selective bacterial transcription inhibitor that effectively disrupts RNA synthesis within bacterial cells. It demonstrates a minimum inhibitory concentration (MIC) of 2 μg/mL against the B. subtilis reporter strain BS2019 and exhibits antimicrobial activity against Staphylococcus aureus. This compound is useful for research applications focused on understanding bacterial gene expression and studying the mechanisms of antibiotic resistance. -
Anti-Bacterial Agent
(Rac)-Besifloxacin hydrochloride is a fourth-generation fluoroquinolone antibiotic that acts as a potent inhibitor of DNA gyrase and topoisomerase IV. This compound exhibits broad-spectrum antibacterial activity against both Gram-negative and Gram-positive aerobic and anaerobic bacteria, making it valuable in combating drug resistance. Additionally, (Rac)-Besifloxacin hydrochloride possesses anti-inflammatory properties, and it is relevant in the study of bacterial conjunctivitis. -
Bacterial DNA Gyrase B Inhibitor
DNA Gyrase-IN-2 is a potent inhibitor of bacterial DNA gyrase B, demonstrating IC50 values of 3.29-10.49 µM for Escherichia coli and 4.41-5.61 µM for Mycobacterium tuberculosis. This compound exhibits significant anti-tubercular and antibacterial activity, making it valuable for research focused on bacterial replication and antibiotic development. Its specific targeting of DNA gyrase B positions it as a promising candidate for further investigation in treating bacterial infections. -
Antibacterial Agent
S-MGB-234 is an antibacterial agent that functions as a minor groove binder, specifically targeting the causative agents of Animal African Trypanosomiasis (AAT). This compound demonstrates potent in vitro activity against Trypanosoma congolense and Trypanosoma vivax, the primary pathogens responsible for AAT. Notably, S-MGB-234 exhibits a unique resistance profile, lacking cross-resistance with existing diamidine agents and not utilizing the transporters commonly associated with diamidines. -
Antibacterial Agent
Lavofloxacin lactate is an antibacterial agent that primarily targets DNA gyrase and topoisomerase IV, leading to the inhibition of DNA replication and repair in bacteria. This broad-spectrum antimicrobial compound exhibits potent bactericidal activity against a wide range of bacterial species. Researchers can utilize Lavofloxacin lactate to investigate bacterial resistance mechanisms, including the analysis of resistance genes and mutations. -
Antibacterial Agent
A-65282 is an antibacterial agent that inhibits P4 DNA unknotting, exhibiting an IC50 value of 8 µg/mL. This compound induces DNA breakage through the action of calf thymus topoisomerase II, making it a valuable tool for studying DNA replication and repair mechanisms. Its targeted enzymatic disruption highlights its potential in antibacterial research contexts. -
Antibacterial Agent
Anti-MRSA agent 28 is an antibacterial agent specifically designed to target multidrug-resistant (MDR) gram-positive bacterial strains. With minimum inhibitory concentrations (MICs) ranging from 0.06 to 0.125 μg/mL, it effectively inhibits bacterial growth by targeting DNA polymerase IIIC, demonstrating an IC50 of 3.80 μg/mL. This compound exhibits strong antibacterial activity and has anti-inflammatory properties, making it a valuable tool for research applications related to the treatment of gram-positive infections. -
Antibacterial Agent
DV-7751A is a fluoroquinolone antibiotic that primarily inhibits the supercoiling activity of DNA gyrases. This compound demonstrates significant antimicrobial activity against a range of bacterial strains, including Streptococcus pneumoniae, Streptococcus pyogenes, and Peptostreptococcus species. Additionally, DV-7751A exhibits a rapid bactericidal effect against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, making it a valuable reagent for research in antibacterial therapeutics. -
Insecticide/Antibacterial Agent
Satranidazole is an orally active insecticide and antimicrobial agent that primarily targets DNA through the formation of reduced nitro intermediates. By inducing helix instability and strand breakage, it exhibits notable antitrichomonal activity against organisms such as Trichomonas vaginalis and Trichomonas foetus, as well as antiamoebic effects in rodent models of hepatic and caecal amoebiasis. Additionally, Satranidazole has been shown to inhibit the replication of bacteriophage φX174 DNA. This compound is valuable for research exploring caecal amoebiasis, trichomoniasis, and anaerobic bacterial infections. -
Bacterial Inhibitor
Aniline-MPB-amino-C3-PBD is a cytotoxic agent targeting bacterial cells through minor-groove binding of DNA. This sequence-selective compound serves as an effective payload for antibody-drug conjugates (ADCs), enhancing their therapeutic efficacy. Its antimicrobial properties make it a valuable tool for research in bacterial inhibition and related applications. -
Bacterial Inhibitor
Py-MPB-amino-C3-PBD is a cytotoxic agent that functions as a bacterial inhibitor. This compound serves as a payload for antibody-drug conjugates (ADCs) and exhibits significant antimicrobial activity. Its unique structure, characterized by a non-alkylating group, makes it a valuable tool for research applications aimed at targeting bacterial infections and developing therapeutics in the field of microbiology. -
Bacterial Inhibitor
Procodazole is a potent bacterial inhibitor that enhances immune response, offering protection against various viral and bacterial infections. In addition to its broad-spectrum antibacterial effects, Procodazole demonstrates antiparasitic activity and serves as a carbonic anhydrase inhibitor, contributing to its antitumor properties. This compound is suitable for research applications focused on infectious diseases and cancer biology. -
Recombinant Bacterial Clones Chromogenic Substrate
X-GalNAc is a chromogenic substrate that specifically targets N-acetyl-β-galactosidase. This reagent is utilized in molecular biology to detect the presence of cloned DNA inserts in bacterial colonies cultured on agar plates. The enzymatic hydrolysis of X-GalNAc results in a distinct color change, facilitating easy identification of recombinant bacterial clones in various genetic research applications. -
Bacterial Inhibitor
Resazurin sodium is a non-toxic, stable redox indicator that targets bacterial activity through its membrane-permeable properties. It serves as a vital tool for assessing cell viability, proliferation, and toxicity in various cell types, including human, plant, animal, bacterial, and fungal cells. Upon reduction, Resazurin sodium transforms into Resorufin, a highly fluorescent compound, enabling sensitive detection and quantification of cellular processes under fluorescent microscopy or spectrophotometry. -
Antibacterial Agent
ANS ammonium is a potent antibacterial agent that also serves as a textile dye. It functions as a fluorescence probe, enabling the detection of various biological interactions. Additionally, ANS ammonium is known to inhibit the binding of triiodothyronine to thyroxine binding globulin, making it useful in radioimmunoassays for triiodothyronine analysis. -
Bacterial Inhibitor
4-Methylherniarin, a coumarin derivative, exhibits antibacterial activity by effectively inhibiting both gram-positive and gram-negative bacterial strains. It demonstrates significant antimicrobial efficacy against B. subtilis and S. sonnei, with IC50 values of 11.76 μg/ml and 13.47 μg/ml, respectively. This compound serves as a valuable tool for research applications focused on combating bacterial infections and elucidating mechanisms of action in microbial resistance. -
Bacterial Metabolite
12-Tridecenoic acid is a bacterial metabolite that plays a crucial role in the regulation of lipid metabolism. It promotes the expression of acetyl-CoA carboxylase α (ACC) while inhibiting carnitine palmitoyltransferase 1A (CPT1A), contributing to the development of hepatic steatosis. This compound is relevant for research in metabolic diseases and cellular lipid regulation. -
Antibacterial Agent
Metioprim is a competitive inhibitor of bacterial dihydrofolate reductase (DHFR), targeting critical pathways in bacterial folate metabolism. It exhibits potent antibacterial activity against anaerobic bacteria and demonstrates synergistic effects when combined with DDS against E. coli and various mycobacterial strains. This reagent is valuable for antibacterial research and development, particularly in studies focused on antibiotic resistance and the efficacy of combination therapies. -
Antibacterial Agent
AR-102 is an antibacterial agent that exhibits potent inhibitory activity against Staphylococcus aureus. It demonstrates competitive inhibition of the F98Y mutant dihydrofolate reductase (DHFR) with a Ki value of 0.22 nM. Structural studies have characterized AR-102 as forming a ternary complex with NADPH in both wild-type and TMP-resistant F98Y mutant S. aureus DHFR, making it a valuable compound for research on antibacterial resistance mechanisms. -
Bacterial Inhibitor
N-Butanoyl-L-homoserine lactone (C4-HSL) is a bacterial inhibitor that functions as a signaling molecule in quorum sensing. This compound demonstrates significant antibacterial activity and effectively disrupts biofilm formation, particularly in Pseudomonas aeruginosa. Research applications include studying bacterial communication and developing strategies to combat antibiotic-resistant infections through targeted inhibition of quorum sensing pathways. -
Bacterial Inhibitor
2-Ethyl-6-methylphenol is an alkylphenol with significant antibacterial properties. This compound has demonstrated efficacy in inhibiting bacterial growth and exhibits potential insecticidal activity, making it a valuable tool in microbiological research and pest control studies. Its role as a bacterial inhibitor can facilitate investigations into microbial resistance and the development of novel antimicrobial agents. -
Antibacterial Agent
4-Chloro-2-methylphenol is an antibacterial agent that effectively inhibits bacterial growth through disruption of cell membrane integrity. Its broad-spectrum antimicrobial activity makes it suitable for use in various pharmaceutical applications, particularly as a preservative and excipient in formulations. This compound is also valuable in research settings focused on studying antibacterial mechanisms and developing new antimicrobial therapies. -
Anti-bacterial Agent
Perillene is a natural compound derived from essential oils, primarily recognized for its antibacterial properties. It exhibits significant antibacterial activity against various pathogens, making it a valuable reagent for research in microbial inhibition and infection prevention. Additionally, perillene has been investigated for its potential antitumor effects, contributing to studies focused on cancer therapeutics and natural product research. -
Antibacterial agent
Gypsogenic acid is a triterpenoid acid with established antibacterial properties, primarily targeting oral bacterial pathogens. It has demonstrated effective minimum inhibitory concentration (MIC) values ranging from 50 to 200 μg/mL against Enterococcus faecalis, Streptococcus salivarius, Streptococcus haematococcus, Streptococcus mutans, and Streptococcus sobrinus. Additionally, Gypsogenic acid has been shown to induce blood cortisone cleavage in isolated mice, with an IC50 of 56.6 μM, making it a promising candidate for further research in antibacterial and trypanoidal applications. -
Antibacterial Agent
Antibacterial agent 265 is a potent antibacterial compound targeting various bacterial strains. It exhibits significant activity against both gram-positive organisms such as Staphylococcus aureus, Micrococcus luteus, and Bacillus subtilis, as well as gram-negative bacteria including Escherichia coli, Pseudomonas aeruginosa, and Flavobacterium devorans. This compound is valuable for research applications related to infection control, antimicrobial resistance, and the development of new antibacterial therapies.

